US Stock MarketDetailed Quotes

NDRA ENDRA Life Sciences

Watchlist
  • 5.5100
  • +0.1400+2.61%
Close Dec 20 16:00 ET
  • 5.5100
  • 0.00000.00%
Post 16:45 ET
2.96MMarket Cap-0.03P/E (TTM)

ENDRA Life Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-51.77%1.51M
-25.50%2.23M
-5.40%2.78M
-20.04%10.52M
-56.00%1.46M
-8.43%3.13M
-16.16%2.99M
2.94%2.94M
14.43%13.16M
7.87%3.31M
Selling and administrative expenses
-52.24%714.57K
-5.01%1.51M
12.34%1.74M
-16.45%5.52M
-46.76%878.43K
-5.72%1.5M
-7.53%1.59M
-5.74%1.55M
9.77%6.6M
0.08%1.65M
-Selling and marketing expense
-65.83%83.16K
-34.23%162.95K
31.41%238.66K
-42.58%820.55K
-54.76%147.83K
-42.12%243.33K
-27.56%247.77K
-46.57%181.62K
32.90%1.43M
-14.48%326.77K
-General and administrative expense
-49.60%631.41K
0.37%1.35M
9.80%1.5M
-9.23%4.7M
-44.79%730.6K
7.41%1.25M
-2.57%1.35M
4.92%1.37M
4.73%5.17M
4.47%1.32M
Research and development costs
-51.35%794.44K
-48.84%716.37K
-25.14%1.04M
-23.66%5M
-65.17%579.35K
-10.79%1.63M
-24.21%1.4M
14.70%1.39M
19.55%6.55M
16.90%1.66M
Operating profit
51.77%-1.51M
25.50%-2.23M
5.40%-2.78M
20.04%-10.52M
56.00%-1.46M
8.43%-3.13M
16.16%-2.99M
-2.94%-2.94M
-14.43%-13.16M
-7.87%-3.31M
Net non-operating interest income expense
Other net income (expense)
-3,093.96%-845.08K
-99.61%1.7K
241.63%4.84K
2,238.51%460.49K
-107.38%-1.76K
222.66%28.23K
2,357.84%437.43K
-16.54%-3.42K
-108.06%-21.53K
171.89%23.79K
Gain on sale of security
---910.6K
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
132.15%65.53K
-99.61%1.7K
241.63%4.84K
2,238.51%460.49K
-107.38%-1.76K
222.66%28.23K
2,357.84%437.43K
-16.54%-3.42K
48.17%-21.53K
171.89%23.79K
Income before tax
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
9.87%-3.1M
28.79%-2.56M
-2.96%-2.94M
-17.34%-13.18M
-5.96%-3.29M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
9.87%-3.1M
28.79%-2.56M
-2.96%-2.94M
-17.34%-13.18M
-5.96%-3.29M
Net income continuous Operations
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
9.87%-3.1M
28.79%-2.56M
-2.96%-2.94M
-17.34%-13.18M
-5.96%-3.29M
Minority interest income
Net income attributable to the parent company
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
9.87%-3.1M
28.79%-2.56M
-2.96%-2.94M
-17.34%-13.18M
-5.96%-3.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
9.87%-3.1M
28.79%-2.56M
-2.96%-2.94M
-16.09%-13.18M
-5.96%-3.29M
Basic earnings per share
99.38%-4.4013
81.40%-140
72.04%-455
65.35%-2.76K
94.89%-92.02
62.98%-706.2
63.25%-752.5
30.08%-1.63K
17.84%-7.98K
33.55%-1.8K
Diluted earnings per share
99.38%-4.4013
81.40%-140
72.04%-455
65.35%-2.76K
94.89%-92.02
62.98%-706.2
63.25%-752.5
30.08%-1.63K
17.84%-7.98K
33.55%-1.8K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense -51.77%1.51M -25.50%2.23M -5.40%2.78M -20.04%10.52M -56.00%1.46M -8.43%3.13M -16.16%2.99M 2.94%2.94M 14.43%13.16M 7.87%3.31M
Selling and administrative expenses -52.24%714.57K -5.01%1.51M 12.34%1.74M -16.45%5.52M -46.76%878.43K -5.72%1.5M -7.53%1.59M -5.74%1.55M 9.77%6.6M 0.08%1.65M
-Selling and marketing expense -65.83%83.16K -34.23%162.95K 31.41%238.66K -42.58%820.55K -54.76%147.83K -42.12%243.33K -27.56%247.77K -46.57%181.62K 32.90%1.43M -14.48%326.77K
-General and administrative expense -49.60%631.41K 0.37%1.35M 9.80%1.5M -9.23%4.7M -44.79%730.6K 7.41%1.25M -2.57%1.35M 4.92%1.37M 4.73%5.17M 4.47%1.32M
Research and development costs -51.35%794.44K -48.84%716.37K -25.14%1.04M -23.66%5M -65.17%579.35K -10.79%1.63M -24.21%1.4M 14.70%1.39M 19.55%6.55M 16.90%1.66M
Operating profit 51.77%-1.51M 25.50%-2.23M 5.40%-2.78M 20.04%-10.52M 56.00%-1.46M 8.43%-3.13M 16.16%-2.99M -2.94%-2.94M -14.43%-13.16M -7.87%-3.31M
Net non-operating interest income expense
Other net income (expense) -3,093.96%-845.08K -99.61%1.7K 241.63%4.84K 2,238.51%460.49K -107.38%-1.76K 222.66%28.23K 2,357.84%437.43K -16.54%-3.42K -108.06%-21.53K 171.89%23.79K
Gain on sale of security ---910.6K ---- ---- ---- ---- ---- ---- ---- ---- ----
Other non- operating income (expenses) 132.15%65.53K -99.61%1.7K 241.63%4.84K 2,238.51%460.49K -107.38%-1.76K 222.66%28.23K 2,357.84%437.43K -16.54%-3.42K 48.17%-21.53K 171.89%23.79K
Income before tax 24.08%-2.35M 12.83%-2.23M 5.68%-2.78M 23.67%-10.06M 55.63%-1.46M 9.87%-3.1M 28.79%-2.56M -2.96%-2.94M -17.34%-13.18M -5.96%-3.29M
Income tax 0 0 0 0 0 0 0 0 0 0
Net income 24.08%-2.35M 12.83%-2.23M 5.68%-2.78M 23.67%-10.06M 55.63%-1.46M 9.87%-3.1M 28.79%-2.56M -2.96%-2.94M -17.34%-13.18M -5.96%-3.29M
Net income continuous Operations 24.08%-2.35M 12.83%-2.23M 5.68%-2.78M 23.67%-10.06M 55.63%-1.46M 9.87%-3.1M 28.79%-2.56M -2.96%-2.94M -17.34%-13.18M -5.96%-3.29M
Minority interest income
Net income attributable to the parent company 24.08%-2.35M 12.83%-2.23M 5.68%-2.78M 23.67%-10.06M 55.63%-1.46M 9.87%-3.1M 28.79%-2.56M -2.96%-2.94M -17.34%-13.18M -5.96%-3.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 24.08%-2.35M 12.83%-2.23M 5.68%-2.78M 23.67%-10.06M 55.63%-1.46M 9.87%-3.1M 28.79%-2.56M -2.96%-2.94M -16.09%-13.18M -5.96%-3.29M
Basic earnings per share 99.38%-4.4013 81.40%-140 72.04%-455 65.35%-2.76K 94.89%-92.02 62.98%-706.2 63.25%-752.5 30.08%-1.63K 17.84%-7.98K 33.55%-1.8K
Diluted earnings per share 99.38%-4.4013 81.40%-140 72.04%-455 65.35%-2.76K 94.89%-92.02 62.98%-706.2 63.25%-752.5 30.08%-1.63K 17.84%-7.98K 33.55%-1.8K
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --
Heat List
US
Overall
Symbol
Price
% Chg

No Data